Literature DB >> 28839772

Ketamine as a possible cause of cirrhosis in a patient with chronic pain.

Roisin Bevan1, Denis Burke2.   

Abstract

Ketamine has been typically administered in short-term, few doses in the clinical setting of acute pain. Its hallucinogenic side effects have made it popular as a recreational drug. Reports of urological, biliary and liver abnormalities have been reported, mainly in cases of abuse. It is now increasingly used for chronic pain conditions, and here we report liver abnormalities and ultimately cirrhosis in an adult on regular ketamine for chronic facial pain. Abnormal liver function tests were detected incidentally, and with no other cause for liver disease found, liver biopsy was performed. This showed fibrosis with incomplete cirrhosis.

Entities:  

Keywords:  Adverse Drug Reactions; Chronic Liver Disease; Cirrhosis

Year:  2013        PMID: 28839772      PMCID: PMC5369745          DOI: 10.1136/flgastro-2013-100378

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  16 in total

1.  'Street ketamine'-associated bladder dysfunction: a report of ten cases.

Authors:  Petty S K Chu; S C Kwok; K M Lam; T Y Chu; Steve W H Chan; C W Man; W K Ma; K L Chui; M K Yiu; Y C Chan; M L Tse; F L Lau
Journal:  Hong Kong Med J       Date:  2007-06-21       Impact factor: 2.227

2.  Dilated common bile ducts in ketamine abusers.

Authors:  S H Ng; Herman K H Lee; Y C Chan; F L Lau
Journal:  Hong Kong Med J       Date:  2009-04       Impact factor: 2.227

3.  Ketamine-induced biliary dilatation: from Hong Kong to New York.

Authors:  Ellen Gutkin; Syed A Hussain; Sang H Kim
Journal:  J Addict Med       Date:  2012-03       Impact factor: 3.702

4.  Upper gastrointestinal problems in inhalational ketamine abusers.

Authors:  Tai Lun Poon; Ka Fai Wong; Man Yee Chan; Ka Wai Fung; Sau Kwan Chu; Chi Wai Man; Ming Kwong Yiu; Siu Kee Leung
Journal:  J Dig Dis       Date:  2010-04       Impact factor: 2.325

5.  Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.

Authors:  Ingeborg M Noppers; Marieke Niesters; Leon P H J Aarts; Martin C R Bauer; Asbjørn M Drewes; Albert Dahan; Elise Y Sarton
Journal:  Pain       Date:  2011-05-04       Impact factor: 6.961

Review 6.  Ketamine for the treatment of chronic non-cancer pain.

Authors:  Ingeborg Noppers; Marieke Niesters; Leon Aarts; Terry Smith; Elise Sarton; Albert Dahan
Journal:  Expert Opin Pharmacother       Date:  2010-10       Impact factor: 3.889

7.  Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney.

Authors:  M S M Wai; W M Chan; A Q Zhang; Y Wu; D T Yew
Journal:  Hum Exp Toxicol       Date:  2012-02-21       Impact factor: 2.903

8.  Side effects of ketamine in the long-term treatment of neuropathic pain.

Authors:  Petr Cvrcek
Journal:  Pain Med       Date:  2008-03       Impact factor: 3.750

9.  Dilated common bile ducts mimicking choledochal cysts in ketamine abusers.

Authors:  S W Wong; K F Lee; John Wong; Wilson W C Ng; Y S Cheung; Paul B S Lai
Journal:  Hong Kong Med J       Date:  2009-02       Impact factor: 2.227

10.  Obstructive nephropathy and kidney injury associated with ketamine abuse.

Authors:  Nicholas M Selby; John Anderson; Peter Bungay; Lindsay J Chesterton; Nitin V Kolhe
Journal:  NDT Plus       Date:  2008-05-21
View more
  1 in total

1.  Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series.

Authors:  Samantha Cotter; Jennie Wong; Neha Gada; Rajdeep Gill; S Christopher Jones; Grace Chai; Daniel Foster; Mark Avigan; Mallika Mundkur
Journal:  Drug Saf       Date:  2021-10-26       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.